Calumet (NASDAQ:CLMT – Free Report) had its target price lifted by TD Cowen from $19.00 to $25.00 in a research note released on Thursday morning, Marketbeat Ratings reports. They currently have a hold rating on the oil and gas company’s stock.
A number of other research analysts have also recently commented on the company. The Goldman Sachs Group upped their price objective on Calumet from $20.00 to $24.00 and gave the company a “buy” rating in a report on Friday, January 30th. Weiss Ratings restated a “sell (d-)” rating on shares of Calumet in a research report on Monday, December 29th. Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. HC Wainwright reissued a “buy” rating and set a $33.00 price objective on shares of Calumet in a research report on Monday, November 10th. Finally, Wall Street Zen lowered shares of Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. Four analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Calumet has a consensus rating of “Hold” and an average price target of $24.00.
Get Our Latest Analysis on Calumet
Calumet Trading Up 3.3%
Calumet (NASDAQ:CLMT – Get Free Report) last posted its earnings results on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share for the quarter, beating the consensus estimate of ($0.67) by $0.24. The firm had revenue of ($3,098.50) million during the quarter, compared to analyst estimates of $1.04 billion. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.47) earnings per share. As a group, analysts forecast that Calumet will post -3.02 EPS for the current year.
Institutional Investors Weigh In On Calumet
Several institutional investors and hedge funds have recently modified their holdings of the company. Covestor Ltd boosted its holdings in Calumet by 29.1% during the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after acquiring an additional 492 shares during the period. O Keefe Stevens Advisory Inc. lifted its position in shares of Calumet by 2.2% during the third quarter. O Keefe Stevens Advisory Inc. now owns 27,416 shares of the oil and gas company’s stock worth $500,000 after purchasing an additional 599 shares in the last quarter. ProShare Advisors LLC lifted its position in shares of Calumet by 6.9% during the fourth quarter. ProShare Advisors LLC now owns 12,613 shares of the oil and gas company’s stock worth $251,000 after purchasing an additional 817 shares in the last quarter. Aster Capital Management DIFC Ltd boosted its stake in shares of Calumet by 294.7% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after purchasing an additional 1,229 shares during the period. Finally, Islay Capital Management LLC purchased a new position in shares of Calumet in the fourth quarter valued at approximately $25,000. Hedge funds and other institutional investors own 34.41% of the company’s stock.
More Calumet News
Here are the key news stories impacting Calumet this week:
- Positive Sentiment: HC Wainwright keeps a “Buy” rating and a $33 price target on CLMT, a level above the current price that supports upside expectations for investors. The firm continues to publish multi-year recovery forecasts despite near-term losses. HC Wainwright Research Coverage
- Neutral Sentiment: Reported short-interest data shows 0 shares short and a 0.0 days-to-cover metric — likely a reporting anomaly. If accurate, negligible short interest removes a potential downside pressure, but the entry appears unreliable and should be viewed cautiously.
- Neutral Sentiment: A FY2029 earnings forecast was published by HC Wainwright (reported on AmericanBankingNews), but the item provides a forward-looking projection without new operational details; useful for modeling but not an immediate catalyst. FY2029 Forecast
- Neutral Sentiment: A PR Newswire release highlights record sales for TRUFUEL®. If TRUFUEL is part of Calumet’s branded products mix, rising consumer/retail sales support longer-term revenue diversification; however, the release is a general industry/brand sales item rather than direct corporate financial guidance. TRUFUEL Record Sales
- Negative Sentiment: TD Cowen raised its price target from $19 to $25 but maintained a “Hold” rating — their $25 target implies downside relative to the current trade level, signaling limited near-term upside from this shop and offering a mixed signal despite the higher target. TD Cowen Target Update
- Negative Sentiment: HC Wainwright materially lowered near- and medium-term EPS forecasts (FY2026, FY2027 and FY2028 revisions downward), trimming FY2026 to a larger loss and reducing FY2028 upside. Those cuts are a direct negative to valuation and short-term expectations despite the maintained Buy rating and $33 target. HC Wainwright EPS Revisions
Calumet Company Profile
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Featured Articles
- Five stocks we like better than Calumet
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
